Its 2025 comparison puts the two biggest GLP-1 drugs at roughly double the combined revenue of the two AI labs, with a chart attached.
Recap by typeshit. Post by Social Capital on X.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
PBS News reports roughly one in eight Americans are on GLP-1 weight loss drugs and looks at what comes with their popularity.
TheStreet looks at people spending heavily on peptides each month and the regulatory trouble now facing what they buy.
Loading…